{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:35:37Z","timestamp":1791214537853,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.jvir.2010.05.020","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T09:42:09Z","timestamp":1283334129000},"page":"1527-1532","source":"Crossref","is-referenced-by-count":55,"title":["Transcatheter Arterial Chemoembolization for Liver Metastases in Patients with Adrenocortical Carcinoma"],"prefix":"10.1016","volume":"21","author":[{"given":"Julien","family":"Cazejust","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"De Ba\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Auperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Deschamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Hechelhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdel-Rehim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Leboulleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2010.05.020_bib1","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1023\/A:1008257530919","article-title":"Adrenocortical carcinoma","volume":"8","author":"Gicquel","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jvir.2010.05.020_bib2","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jvir.2010.05.020_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jvir.2010.05.020_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jvir.2010.05.020_bib5","article-title":"Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors","volume":"61","author":"Gicquel","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jvir.2010.05.020_bib6","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jvir.2010.05.020_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2006-0706","article-title":"Prognostic parameters of metastatic adrenocortical carcinoma","volume":"92","author":"Assie","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jvir.2010.05.020_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1677\/erc.1.01025","article-title":"Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial","volume":"12","author":"Berruti","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jvir.2010.05.020_bib9","first-page":"149","article-title":"Adrenocortical carcinoma\u2013diagnostic and therapeutical implications","volume":"159","author":"Ahlman","year":"1993","journal-title":"Eur J Surg"},{"key":"10.1016\/j.jvir.2010.05.020_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1677\/erc.1.01029","article-title":"Management of patients with adrenal cancer: recommendations of an international consensus conference","volume":"12","author":"Schteingart","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jvir.2010.05.020_bib11","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N","article-title":"Adrenal cortical carcinoma","volume":"72","author":"Wooten","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2010.05.020_bib12","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/1097-0142(20010915)92:6<1385::AID-CNCR1461>3.0.CO;2-2","article-title":"Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p\u2032DDD) levels on the treatment of patients with adrenocortical carcinoma","volume":"92","author":"Baudin","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2010.05.020_bib13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/bjc.1994.183","article-title":"Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients","volume":"69","author":"Haak","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jvir.2010.05.020_bib14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2010.05.020_bib15","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/annonc\/mdf291","article-title":"Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma","volume":"13","author":"Baudin","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jvir.2010.05.020_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/jc.2005-1739","article-title":"Emerging treatment strategies for adrenocortical carcinoma: a new hope","volume":"91","author":"Kirschner","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jvir.2010.05.020_bib17","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1210\/jc.2007-2564","article-title":"Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine","volume":"93","author":"Quinkler","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jvir.2010.05.020_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-009-1083-9","article-title":"Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma","volume":"65","author":"Haluska","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jvir.2010.05.020_bib19","doi-asserted-by":"crossref","unstructured":"Lindsay CR, Chan E, Evans TR, et al. Phase I dose escalation study of continuous oral dosing of OSI-906, an insulin like growth factor-1 receptor (IGF-1R) tyrosine kinase inhibitor, in patients with advanced solid tumors. Presented at the 45th Scientific Assembly of the American Society of Clinical Oncology; May 29 to June 2, 2009; Orlando, FL.","DOI":"10.1200\/jco.2009.27.15_suppl.2559"},{"key":"10.1016\/j.jvir.2010.05.020_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1242\/jeb.025262","article-title":"Physiological variation in amethyst sunbirds (Chalcomitra amethystina) over an altitudinal gradient in winter","volume":"212","author":"Lindsay","year":"2009","journal-title":"J Exp Biol"},{"key":"10.1016\/j.jvir.2010.05.020_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3322\/canjclin.37.6.348","article-title":"Adrenocortical carcinoma","volume":"37","author":"Brennan","year":"1987","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jvir.2010.05.020_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2010.05.020_bib23","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.0.CO;2-E","article-title":"Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors","volume":"83","author":"Eriksson","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2010.05.020_bib24","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/cncr.21389","article-title":"Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival","volume":"104","author":"Gupta","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2010.05.020_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00330-002-1558-0","article-title":"Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors","volume":"13","author":"Roche","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jvir.2010.05.020_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jvir.2010.05.020_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.jvir.2010.05.020_bib28","first-page":"1751","article-title":"Prognostic factors for chemoembolization in liver metastasis from endocrine tumors","volume":"51","author":"Roche","year":"2004","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jvir.2010.05.020_bib29","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2010.05.020_bib30","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","article-title":"Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics","volume":"46","author":"Varela","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2010.05.020_bib31","unstructured":"Coenegrachts K, de Ba\u00e8re T, Abdel Rehim M, Lafont C, Dromain C, Hakime A. Transarterial chemoembolization (TACE) of neuroendocrine hepatic metastases using drug eluting beads. Presented at the 91st Scientific Assembly of the Radiological Society of North America; November 27 to December 2, 2005; Chicago, IL."},{"key":"10.1016\/j.jvir.2010.05.020_bib32","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1158\/1078-0432.CCR-05-2225","article-title":"New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer","volume":"12","author":"Hong","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jvir.2010.05.020_bib33","first-page":"502","article-title":"Adrenocortical carcinoma","volume":"57","author":"Decker","year":"1991","journal-title":"Am Surg"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104431000624X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104431000624X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T19:29:26Z","timestamp":1636313366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105104431000624X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S105104431000624X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2010.05.020","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}